Research

The T.J. Martell Foundation fills an important niche in the field of cancer, focusing on funding early-stage cancer research. To take an early-research finding and develop an effective therapy can take years, if not decades, at an enormous cost.¹ Our investments in early cancer research play a critical role in developing the “proof of concept” necessary to unlock more significant National Institutes of Health grants needed to pursue clinical trials and exciting new treatments and cures for cancer. 

We proudly fund a continuum of innovation that produces breakthroughs and advances in cancer research. Our approach follows a rigorous peer-review process whereby qualified research institutions’ proposals are assessed, reviewed, and judged by the T.J. Martell Foundation Scientific Advisory Committee—a volunteer group of highly-renowned oncology and multi-disciplinary experts from leading institutions worldwide. These esteemed experts and leaders ensure that the foundation’s valuable funding is allocated to where it matters most, targeting early-stage cancer research with the promise of producing new cancer treatments and cures. In doing so, the Committee nurtures the next generation of scientists who will bring us that much closer to a world without cancer.

¹ National Cancer Institute, “NCI’s Role in Cancer Research”